2013 Oil Packaging Patients 
The Cannigma
FEBRUARY 26, 2021
What is CBG oil? CBG oils are oils that contain a substantial amount of CBG. There are a few ways to manufacture such oils, primarily using an extraction of isolated CBG from either a hemp or marijuana plant, or a whole plant extraction that may also include other cannabinoids, terpenes and other phytonutrients.
The Cannigma
OCTOBER 25, 2021
In 2018 Canada legalized recreational cannabis use, becoming the first G7 country to do so and only the second country after Uruguay, which legalized cannabis in 2013. Patients in Canada can legally possess the lesser of 150 grams or a 30-day supply of dried cannabis, as well as the 30 grams allowed for non-medical purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 9, 2019
Research has found cannabis can help those diagnosed with either type 1 or 2 diabetes, and those who suffer complications, and a landmark study published in the American Journal of Medicine in 2013 said marijuana compounds can also help control blood sugar. It’s about finding the end solution for the patient.” Photo: Google Maps.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.
NORML
FEBRUARY 26, 2019
Other parts of the proposal will no longer permit growing marijuana plants by and for medical marijuana patients who can’t or won’t demonstrate hardship, instead driving them toward retail sales at compassion centers. per-package limit.). Massachusetts has no limit on marijuana-product potency. Thou shalt not grow.
Cannabis Law Report
OCTOBER 29, 2019
“The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.
Cannabis Law Report
JULY 12, 2019
Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.
Expert insights. Personalized for you.
100 
Let's personalize your content